CI: Inverse Head And Shoulders detected on 15 Sep 2026

CI is forming an inverse head-and-shoulders pattern, a bullish reversal setup that suggests potential upside breakout. The stock is currently at $290.05, positioned between key support at $272.50 and resistance at $233.86 (note: resistance level appears to be a prior low, with current price well above it). The pattern structure scores 11/15, indicating moderate structural integrity. Volume support is solid at 12/12, confirming institutional accumulation during the pattern formation. However, breakout quality scores only 5/13, suggesting the move lacks conviction so far. Overall score of 59/98 reflects a setup with technical merit but execution risk. RSI at 60.43 remains neutral, not yet overbought.

Cigna reported Q2 2026 EPS of $7.78, beating estimates and up from $7.20 in the prior-year quarter. Bernstein initiated a Buy rating on September 9, 2026, while Evercore ISI initiated coverage with an In Line rating and $290 price target. Wall Street consensus shows 12 Buy ratings, 5 Hold ratings, and zero Sell ratings from 17 analysts. The recent earnings momentum and raised 2026 profit expectations support the investment case, though pressure on prescription growth or healthcare cost dynamics could constrain valuation. The company is expected to report next earnings on October 29, 2026. Health care sector remains in bullish regime (score 0.11), providing favorable backdrop for the breakout attempt.

A successful inverse head-and-shoulders breakout would target $303.79 (conservative measure move), representing approximately 4.8% upside from current price. Volume confirmation is essential—sustained closes above resistance with above-average volume would validate the pattern. The 58.46% win probability aligns with historical inverse H&S success rates in this sector. Pattern invalidation occurs on a close below the key support level of $272.50, representing the neckline. The low volatility environment (ATR 2.14%, beta 0.34) suggests controlled risk parameters, though limited volatility may constrain explosive breakout momentum.

The inverse H&S structure shows moderate weakness with breakout quality at only 5/13—the pattern lacks the convincing price momentum typically needed for high-conviction breakouts. Volume ratio at 0.93 is below average, indicating lukewarm institutional interest relative to 20-day average. Next earnings report on October 29, 2026 introduces event risk just six weeks out; any disappointment could invalidate the pattern before it resolves. Healthcare cost pressures remain a sector headwind per analyst commentary. The stock is down 2.12% over three months despite recent weekly gains, suggesting underlying weakness. Extremely low beta (0.34) means CI will underperform if broad market rallies, limiting participation in upside scenarios.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.